Literature DB >> 22956770

Human antral follicles <6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression.

L Guzman1, T Adriaenssens, C Ortega-Hrepich, F K Albuz, I Mateizel, P Devroey, M De Vos, J Smitz.   

Abstract

Within the context of an oocyte in vitro maturation (IVM) program for reproductive treatment, oocyte cumulus complexes (COCs) derived from follicles <6 mm in patients with PCOS were matured in vitro. Key transcripts related to meiotic maturation (FSHR, LHCGR, EGFR, PGR) and oocyte competence (AREG, ADAMTS, HAS2, PTGS2) were quantified in cumulus cells (CCs) before and after maturation. Control CC samples were collected from PCOS and normo-ovulatory patients who had undergone conventional gonadotrophin stimulation for IVF/ICSI. Additional control samples from a non-stimulated condition were obtained ex vivo from patients undergoing ovariectomy for fertility preservation. Expression data from CCs from follicles with a diameter of <6 mm before (IVM-CCs) and after in vitro maturation (IVM-CCs) were obtained after pooling CCs into four groups in relation to the percentage of matured (MII) oocytes obtained after 40 h of IVM (0; 40-60; 61-80; 100% MII) and values were compared with in vivo matured controls (IVO-CCs). Genes encoding key receptors mediating meiotic resumption are expressed in human antral follicles of <6 mm before and after IVM. The expression levels of FSHR, EGFR and PGR in CCs were significantly down-regulated in the IVO-CCs groups and in the 100% MII IVM group compared with the BM groups; all the receptors studied in the 100% MII IVM group reached an expression profile similar to that of IVO-CCs. However, after maturation in a conventional IVF/ICSI cycle, IVO-CCs from large follicles contained significantly increased levels of ADAMTS1, AREG, HAS2 and PTGS2 compared with IVM-CCs and IVM-CCs; the expression patterns for these genes in all IVM-CCs were unchanged compared with IVM-CCs. In conclusion, genes encoding receptors involved in oocyte meiotic resumption appeared to be expressed in CCs of small human antral follicles. Expression levels of genes-encoding factors reflecting oocyte competence were significantly altered in IVM-CCs compared with in vivo matured oocytes from large follicles. Observed differences might be explained by the different stimulation protocols, doses of gonadotrophin or by the intrinsic differences between in vivo and in vitro maturation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956770     DOI: 10.1093/molehr/gas038

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  13 in total

1.  Cumulus cell pappalysin-1, luteinizing hormone/choriogonadotropin receptor, amphiregulin and hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 mRNA levels associate with oocyte developmental competence and embryo outcomes.

Authors:  Richard J Kordus; Akhtar Hossain; Michael C Corso; Hrishikesh Chakraborty; Gail F Whitman-Elia; Holly A LaVoie
Journal:  J Assist Reprod Genet       Date:  2019-06-11       Impact factor: 3.412

2.  Follicle-stimulating hormone regulates expression and activity of epidermal growth factor receptor in the murine ovarian follicle.

Authors:  Stephany El-Hayek; Isabelle Demeestere; Hugh J Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

3.  Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin.

Authors:  Katherine L Rosewell; Linah Al-Alem; Farnosh Zakerkish; Lauren McCord; James W Akin; Charles L Chaffin; Mats Brännström; Thomas E Curry
Journal:  Fertil Steril       Date:  2014-12-13       Impact factor: 7.329

Review 4.  Oocyte quality following in vitro follicle development†.

Authors:  Jing Xu; Mary B Zelinski
Journal:  Biol Reprod       Date:  2022-02-22       Impact factor: 4.285

5.  In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

Authors:  Ingrid Segers; Ileana Mateizel; Ellen Van Moer; Johan Smitz; Herman Tournaye; Greta Verheyen; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2015-08-08       Impact factor: 3.412

6.  A threshold concentration of FSH is needed during IVM of ex vivo collected human oocytes.

Authors:  Jesús Cadenas; Dmitry Nikiforov; Susanne Elisabeth Pors; Lenin Arturo Zuniga; Yu Wakimoto; Zeinab Ghezelayagh; Linn Salto Mamsen; Stine Gry Kristensen; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2021-05-28       Impact factor: 3.357

7.  Live births after in vitro maturation of oocytes in women who had suffered adnexal torsion and unilateral oophorectomy following conventional ovarian stimulation.

Authors:  Dóra Vesztergom; Ingrid Segers; Linde Mostinckx; Christophe Blockeel; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

8.  The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM.

Authors:  Carolina Ortega-Hrepich; Nikolaos P Polyzos; Ellen Anckaert; Luis Guzman; Herman Tournaye; Johan Smitz; Michel De Vos
Journal:  Reprod Biol Endocrinol       Date:  2014-02-24       Impact factor: 5.211

Review 9.  In vitro maturation of human immature oocytes for fertility preservation and research material.

Authors:  Hiromitsu Shirasawa; Yukihiro Terada
Journal:  Reprod Med Biol       Date:  2017-06-18

Review 10.  The Place of In Vitro Maturation in PCO/PCOS.

Authors:  Shital Julania; Melanie L Walls; Roger Hart
Journal:  Int J Endocrinol       Date:  2018-07-31       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.